Molecular Pharmacology: 38 (4)

October 01, 1990; Volume 38,Issue 4

You have access
Regulation of jun-B gene expression by 1-beta-D-arabinofuranosyl-cytosine in human myeloid leukemia cells.
R Datta, S Kharbanda and D Kufe

Molecular Pharmacology October 1990, 38 (4) 435-439;
You have access
Differentiated induction of cytochrome P450b/e and P450p mRNAs by dose of phenobarbital in primary cultures of adult rat hepatocytes.
T A Kocarek, E G Schuetz and P S Guzelian

Molecular Pharmacology October 1990, 38 (4) 440-444;
You have access
Quantitative evaluation of benzodiazepine receptors in live Papio papio baboons using positron emission tomography.
E Brouillet, C Chavoix, M Khalili-Varasteh, M Bottlaender, P Hantraye, J C Yorke and M Maziere

Molecular Pharmacology October 1990, 38 (4) 445-450;
You have access
Difluoromethylornithine prevents the down-regulation of type I interferon receptors: a possible mechanism for a synergistic antiproliferative effect.
D L Dilollo, M W Beilharz, M C Lai and R F Minchin

Molecular Pharmacology October 1990, 38 (4) 451-454;
You have access
Perturbations of intracellular calcium distribution in kidney cells by nephrotoxic haloalkenyl cysteine S-conjugates.
S Vamvakas, V K Sharma, S S Sheu and M W Anders

Molecular Pharmacology October 1990, 38 (4) 455-461;
You have access
Developmental expression and in situ localization of the phenobarbital-inducible rat hepatic mRNAs for cytochromes CYP2B1, CYP2B2, CYP2C6, and CYP3A1.
C J Omiecinski, C Hassett and P Costa

Molecular Pharmacology October 1990, 38 (4) 462-470;
You have access
Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content.
W K Eng, F L McCabe, K B Tan, M R Mattern, G A Hofmann, R D Woessner, R P Hertzberg and R K Johnson

Molecular Pharmacology October 1990, 38 (4) 471-480;
You have access
Multiple forms of biliverdin reductase: age-related change in pattern of expression in rat liver and brain.
M D Maines

Molecular Pharmacology October 1990, 38 (4) 481-485;
You have access
Hemin administration to rats reduces levels of hepatic mRNAs for phenobarbitone-inducible enzymes.
G Srivastava, A J Hansen, M J Bawden and B K May

Molecular Pharmacology October 1990, 38 (4) 486-493;
You have access
Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors.
J C Martel, A Fournier, S St-Pierre, Y Dumont, M Forest and R Quirion

Molecular Pharmacology October 1990, 38 (4) 494-502;
You have access
Epidermal growth factor stimulates linoleic acid metabolism in BALB/c 3T3 fibroblasts.
W C Glasgow and T E Eling

Molecular Pharmacology October 1990, 38 (4) 503-510;
You have access
Quantitative molecular analysis predicts 5-hydroxytryptamine3 receptor binding affinity.
A W Schmidt and S J Peroutka

Molecular Pharmacology October 1990, 38 (4) 511-516;
You have access
Delineation of muscarinic receptor domains conferring selectivity of coupling to guanine nucleotide-binding proteins and second messengers.
J Wess, T I Bonner, F Dörje and M R Brann

Molecular Pharmacology October 1990, 38 (4) 517-523;
You have access
Nordihydroguaiaretic acid inhibits voltage-activated Ca2+ currents independently of lipoxygenase inhibition.
S J Korn and R Horn

Molecular Pharmacology October 1990, 38 (4) 524-530;
You have access
Agonist-induced desensitization of D1-dopamine receptors linked to adenylyl cyclase activity in cultured NS20Y neuroblastoma cells.
A C Barton and D R Sibley

Molecular Pharmacology October 1990, 38 (4) 531-541;
You have access
Inactivation of tyrosine hydroxylase by pterin substrates following phosphorylation by cyclic AMP-dependent protein kinase.
R Roskoski, H Wilgus and K E Vrana

Molecular Pharmacology October 1990, 38 (4) 541-546;
You have access
Regulation of cAMP metabolism in mouse parotid gland by cGMP and calcium.
E L Watson, J C Singh, C McPhee, J Beavo and K L Jacobson

Molecular Pharmacology October 1990, 38 (4) 547-553;
You have access
Activity of 5,7-dichlorokynurenic acid, a potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site.
B M Baron, B L Harrison, F P Miller, I A McDonald, F G Salituro, C J Schmidt, S M Sorensen, H S White and M G Palfreyman

Molecular Pharmacology October 1990, 38 (4) 554-561;
You have access
Pentoxifylline inhibition of procoagulant activity generated by activated mononuclear phagocytes.
D De Prost, V Ollivier and J Hakim

Molecular Pharmacology October 1990, 38 (4) 562-566;
You have access
Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidine.
V Heinemann, Y Z Xu, S Chubb, A Sen, L W Hertel, G B Grindey and W Plunkett

Molecular Pharmacology October 1990, 38 (4) 567-572;
You have access
Stereoselective S-oxygenation of 2-aryl-1,3-dithiolanes by the flavin-containing and cytochrome P-450 monooxygenases.
J R Cashman and L D Olsen

Molecular Pharmacology October 1990, 38 (4) 573-585;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals